Key Events This Week
30 Mar: Intraday low amid heavy price pressure, closing down 9.58%
1 Apr: Strong intraday high with 8.05% surge, signalling rebound
2 Apr: Moderate gains continue with 2.34% rise
3 Apr: No trading data available
30 March 2026: Sharp Intraday Decline Amid Price Pressure
Gujarat Themis Biosyn Ltd opened the week under significant selling pressure, closing at Rs.227.45, down Rs.24.10 or 9.58% from the previous close. The stock initially gained 2.5% to an intraday high of Rs.257.85 but reversed sharply to hit a day low of Rs.230.05, marking an 8.55% drop within the session. This intraday low was just 3.63% above its 52-week low of Rs.221.70, underscoring the severity of the correction.
The stock’s decline notably outpaced the broader market, with the Sensex falling 2.29% to 32,182.38. Gujarat Themis Biosyn Ltd’s underperformance relative to the Pharmaceuticals & Biotechnology sector was marked, reflecting sector-specific headwinds and heightened volatility. Technical indicators painted a bearish picture, with the stock trading below all major moving averages (5, 20, 50, 100, and 200 days) and exhibiting negative momentum across weekly and monthly MACD and Bollinger Bands.
Despite the steep drop, the On-Balance Volume (OBV) showed mild bullishness on a monthly basis, hinting at some underlying accumulation, though this was insufficient to prevent the sharp intraday fall. The stock’s Mojo Score remained at 37.0 with a 'Sell' rating, reflecting the cautious market stance.
Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.
- - Consistent quarterly delivery
- - Proven staying power
- - Stability with growth
1 April 2026: Strong Rebound with 8.05% Intraday Surge
Following the prior day’s sharp decline, Gujarat Themis Biosyn Ltd staged a notable recovery on 1 April 2026, closing at Rs.245.75, up Rs.18.30 or 8.05%. The stock reached an intraday high of Rs.244.25, a 7.39% rise from the opening price, outperforming both its sector and the Sensex, which gained 1.97% to 32,814.97.
This rebound marked a temporary shift in market sentiment, though the stock remained below all key moving averages, indicating that the broader downtrend was intact. The rally was nearly three times the benchmark’s gain, highlighting strong buying interest during the session. Technical indicators remained mixed, with weekly MACD and Bollinger Bands still bearish, but the Relative Strength Index (RSI) showed bullish tendencies on a weekly basis, suggesting potential for further short-term strength.
Despite the bounce, the Mojo Score and 'Sell' rating persisted, reflecting the need for sustained momentum to confirm a longer-term recovery.
2 April 2026: Continued Moderate Gains
The stock extended its recovery on 2 April, closing at Rs.251.50, up Rs.5.75 or 2.34%. The Sensex was relatively flat, gaining 0.08% to 32,839.65. This modest gain consolidated the prior day’s rebound, though volume remained moderate at 9,275 shares traded. The stock’s position below major moving averages continued to signal caution, despite the positive price action.
Is Gujarat Themis Biosyn Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Weekly Price Performance: Gujarat Themis Biosyn Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-03-30 | Rs.227.45 | -9.58% | 32,182.38 | -2.29% |
| 2026-04-01 | Rs.245.75 | +8.05% | 32,814.97 | +1.97% |
| 2026-04-02 | Rs.251.50 | +2.34% | 32,839.65 | +0.08% |
Key Takeaways from the Week
Volatility and Price Swings: The stock exhibited significant volatility, with a steep 9.58% drop on 30 March followed by an 8.05% rebound on 1 April. This reflects a highly reactive trading environment and sensitivity to market sentiment.
Relative Outperformance: Despite the sharp decline, Gujarat Themis Biosyn Ltd outperformed the Sensex’s 2.29% fall on 30 March and the broader market’s modest gains on subsequent days, ending the week nearly flat versus the Sensex’s 0.29% decline.
Technical Challenges Persist: The stock remains below all major moving averages, with bearish MACD and Bollinger Bands on weekly and monthly charts. This suggests that the recent rebound may be a short-term correction within a broader downtrend.
Mojo Score and Rating: The Mojo Score of 37.0 and 'Sell' rating, unchanged since 21 January 2026, reflect ongoing caution based on financial metrics and technical assessments.
Long-Term Performance Contrast: While recent months have been challenging, Gujarat Themis Biosyn Ltd’s long-term returns remain impressive, with a 3-year gain of 169.74% and a ten-year appreciation exceeding 3,400%, highlighting its historical resilience despite current pressures.
Conclusion
The week ending 3 April 2026 was marked by pronounced volatility for Gujarat Themis Biosyn Ltd, with a sharp initial sell-off followed by a strong recovery. Although the stock outperformed the Sensex over the week, the persistent technical weaknesses and cautious market environment suggest that investors should monitor for confirmation of sustained momentum before considering a longer-term uptrend. The stock’s enduring long-term gains contrast with its recent struggles, underscoring the importance of balancing short-term price action with broader historical context.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
